Replies to post #183522 on OWC Pharmaceutical Research Corp (OWCP)

[PhenixBleu]

SEC Form 8-K is required for material events such as departures of officers. We haven't seen one for Zeevi. I'm still not surprised OTC traders don't understand this requirement. That's the only naivete I see. Choosing not to learn and apply such learning is a choice.

This team has had part-time members all along. Just as Hirsch is on several corporate Boards, and Chairs more than one, Zeevi's research activities span more than one company, and Sinai has several businesses interests.

I can't draw the conclusion any of their team members are in name only as there are no facts to support this claim. Professionals need to quantify and qualify their contributions in the public arena, and each contributor has a professional reputation to maintain.

To me, seeing the Power of Attorney designations being given to Browdy & Neimark is a very significant event, yet not material. It means we're going to see Notices of Allowance for more patent applications. Each attorney name on the Attorney tab means that attorney is able to prosecute that application. Their attorneys have significant experience working with and for the USPTO.

It makes sense to give POA status for aggressive patent prosecution. This frees up the scientists to do what they do best. OWC has never given POA status to a patent law firm before now. This is serious stuff.

http://www.browdyneimark.com/

However, I do agree that it is really naive to believe that just because there hasn't been an official SEC filing of someone's departure, then that must mean he or she is still actively involved with the company. It is not out of the realm of possibility that he or she may be there in name only!